1. Home
  2. CADL vs SIGIP Comparison

CADL vs SIGIP Comparison

Compare CADL & SIGIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CADL
  • SIGIP
  • Stock Information
  • Founded
  • CADL 1999
  • SIGIP N/A
  • Country
  • CADL United States
  • SIGIP United States
  • Employees
  • CADL N/A
  • SIGIP 2650
  • Industry
  • CADL Biotechnology: Pharmaceutical Preparations
  • SIGIP Property-Casualty Insurers
  • Sector
  • CADL Health Care
  • SIGIP Finance
  • Exchange
  • CADL Nasdaq
  • SIGIP Nasdaq
  • Market Cap
  • CADL 185.2M
  • SIGIP N/A
  • IPO Year
  • CADL 2021
  • SIGIP N/A
  • Fundamental
  • Price
  • CADL $6.43
  • SIGIP $18.49
  • Analyst Decision
  • CADL Strong Buy
  • SIGIP
  • Analyst Count
  • CADL 1
  • SIGIP 0
  • Target Price
  • CADL $11.00
  • SIGIP N/A
  • AVG Volume (30 Days)
  • CADL 590.6K
  • SIGIP N/A
  • Earning Date
  • CADL 08-08-2024
  • SIGIP N/A
  • Dividend Yield
  • CADL N/A
  • SIGIP N/A
  • EPS Growth
  • CADL N/A
  • SIGIP N/A
  • EPS
  • CADL N/A
  • SIGIP N/A
  • Revenue
  • CADL N/A
  • SIGIP N/A
  • Revenue This Year
  • CADL N/A
  • SIGIP N/A
  • Revenue Next Year
  • CADL N/A
  • SIGIP N/A
  • P/E Ratio
  • CADL N/A
  • SIGIP N/A
  • Revenue Growth
  • CADL N/A
  • SIGIP N/A
  • 52 Week Low
  • CADL $0.66
  • SIGIP N/A
  • 52 Week High
  • CADL $14.30
  • SIGIP N/A
  • Technical
  • Relative Strength Index (RSI)
  • CADL 48.27
  • SIGIP 50.46
  • Support Level
  • CADL $5.58
  • SIGIP $18.47
  • Resistance Level
  • CADL $6.71
  • SIGIP $18.93
  • Average True Range (ATR)
  • CADL 0.54
  • SIGIP 0.14
  • MACD
  • CADL 0.10
  • SIGIP 0.01
  • Stochastic Oscillator
  • CADL 46.59
  • SIGIP 42.91

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About SIGIP Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B

Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. Since 1977, Selective has focused its sales efforts on small businesses, offering commercial products that include workers' compensation, general liability, property, and auto insurance. Selective also has a small personal insurance segment (under 20% of total premiums), selling auto and homeowner's coverage.

Share on Social Networks: